Sterling Investment Counsel, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1925853 Buffalo, NY

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,138,702

-$88,868 QoQ

Shares Held

9,013

+2.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.68%

of 13F equity value

Holder Rank

#1,010

of 2,266 holders

Holding Since

Dec 2022

13 quarters on record

Voting authority Sole 79% Shared 0% None 21%

Healthcare · as of Jun 30, 2026

Sterling Investment Counsel, LLC holds $9,362,958 across 6 Drug Manufacturers - General names. GILD ranks #4 (12.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,327	$2,791,073
2	ABBV	AbbVie Inc.	9,241	$2,325,405
3	MRK	Merck & Co., Inc.	13,344	$1,714,704
4	GILD	Gilead Sciences, Inc. This page	9,013	$1,138,702
5	JNJ	Johnson & Johnson	4,172	$1,059,562
6	AMGN	Amgen Inc	921	$333,512

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,138,702	9,013	+2.3%	Shares	Sole	2026-07-20
2026-03-31	$1,227,570	8,808	+33.5%	Shares	Sole	2026-04-16
2025-12-31	$809,838	6,598	+1.0%	Shares	Sole	2026-01-27
2025-09-30	$725,163	6,533	-4.8%	Shares	Sole	2025-10-21
2025-03-31	$768,663	6,860	+0.3%	Shares	Sole	2025-04-21
2024-09-30	$573,633	6,842	+7.8%	Shares	Sole	2024-10-22
2024-06-30	$435,536	6,348	+33.7%	Shares	Sole	2024-07-25
2024-03-31	$347,717	4,747	-22.1%	Shares	Sole	2024-04-26
2023-12-31	$493,755	6,095	+9.6%	Shares	Sole	2024-01-12
2023-09-30	$416,740	5,561	+109.0%	Shares	Sole	2023-10-19
2023-06-30	$205,083	2,661	+7.4%	Shares	Sole	2023-07-17
2023-03-31	$205,599	2,478	-18.4%	Shares	Sole	2023-04-18
2022-12-31	$260,812	3,038	—	Shares	Sole	2023-01-20
No filing history on record for this holder in this stock.